Analyst Recommendations

41.87 -0.75(-1.75%)05/17/2024
Ultragenyx Pharmaceutical Inc. (RARE)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Overweight7
Neutral4
Buy3
Outperform1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades